Antigeno hepatitis a

VAQTA 25 UNIDADES/0,5ml SUSPENSION INYECTABLE EN JERINGA PRECARGADA

25 U suspensión inyectable en jeringa precargadaSpainMarketedAuthorised 30 Nov 1997

Packs

Pack	Code	Status
VAQTA 25 UNIDADES/0,5ml SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml + 2 AGUJAS	652442
VAQTA 25 UNIDADES/0,5ml SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jering precargada de 0,5 ml + 1 AGUJA	670075

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Antigeno hepatitis a

VAQTA 25 UNIDADES/0,5ml SUSPENSION INYECTABLE EN JERINGA PRECARGADA

25 U suspensión inyectable en jeringa precargadaSpainMarketedAuthorised 30 Nov 1997

Product informationAsk Osler about it

Packs

Pack	Code	Status
VAQTA 25 UNIDADES/0,5ml SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,5 ml + 2 AGUJAS	652442
VAQTA 25 UNIDADES/0,5ml SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jering precargada de 0,5 ml + 1 AGUJA	670075

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Antigeno hepatitis a
Strength: 25 U
Dosage form: suspensión inyectable en jeringa precargada
Route: vía intramuscular
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 30 Nov 1997
Registration: 61602
Marketing authorisation holder: Laboratorios Abello S.A.
Procedure: National, MRP or DCP
Supply: Medicamento Sujeto A Prescripción Médica

Spain

Havrix 720 Junior, Suspension Inyectable en Jeringa PrecargadaAntigeno hepatitis a · 720 U ELISA · suspensión inyectable en jeringa precargadaSpain

VAQTA 50 UNIDADES/1ml SUSPENSION INYECTABLE EN JERINGA PRECARGADAAntigeno hepatitis a · 50 U · suspensión inyectable en jeringa precargadaSpain

Havrix 1440 Adulto, Suspension Inyectable en Jeringa PrecargadaAntigeno hepatitis a · 1440 U ELISA · suspensión inyectable en jeringa precargadaSpain

VAQTA 25 UNIDADES/ 0,5 ml SUSPENSION INYECTABLEAntigeno hepatitis a · 25 U · suspensión inyectableSpainWithdrawn

VAQTA 50 UNIDADES/1 ml SUSPENSION INYECTABLEAntigeno hepatitis a · 50 U · suspensión inyectableSpainWithdrawn